Navigation Links
Global Atrial Fibrillation Device Market to Grow by Almost 10% Through 2013
Date:11/2/2009

WALTHAM, Mass., Nov. 2 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the atrial fibrillation device market will grow by almost 10% through 2013 in the US, Europe, and Japan. MRG's Global Markets for Atrial Fibrillation Devices 2009 report finds that many patients will be treated with electrophysiology technology and related devices as positive clinical results supporting their use emerges.

Atrial fibrillation, recognized as a significant risk factor for cardiac morbidity and mortality, causes an estimated 15% of all strokes and will remain an important focus for physicians as prevalence of the disease rises. Pharmacotherapy is the primary method of atrial fibrillation management; medical devices are usually reserved for patients who do not respond to drug treatment. However, evidence is growing that for some patients nonpharmacological interventions offer a viable alternative to drugs. Of the devices included in the report, electrophysiology ablation technologies will exhibit the strongest expansion, forecast to exhibit over 24% annual growth over the next five years. The minimally invasive nature of the procedures, as well as their potential to cure atrial fibrillation rather than just manage the symptoms, will fuel this growth. Continued improvements made to electrophysiology technology and growing physician familiarity with the associated procedural techniques will further drive adoption of this treatment through 2013.

"Globally, we've seen the development of a number of advanced devices that deliver more effective treatment of atrial fibrillation," says Dan Whalen, Analyst at MRG. "New electrophysiology catheters in particular have allowed physicians to target the unique physiological demands of atrial fibrillation and will drive procedural growth through 2013 as a result."

MRG's new report, Global Markets for Atrial Fibrillation Devices 2009, provides important insight into the trends that will fuel product use and market growth of atrial fibrillation treatment devices through 2013. Additionally, the report provides full breakdowns of procedures, sales, and prices of electrophysiology catheters, surgical ablation catheters, and cardiac rhythm management devices. This report includes five-year forecasts, up-to-date country-level market shares, and in-depth qualitative insights.

Webinar

Members of the media are welcome to attend our upcoming webinar entitled Devices vs. Drugs: Will Medical Devices Eat Away at Drug Revenues in the Atrial Fibrillation Market?

This webinar will be held on Tuesday, November 24, 2009 at 11 a.m. U.S. Eastern Time. For more information, please contact Amy Krohn at 416-364-7776 ext. 101 or by email at akrohn@mrg.net.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the health care sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack(TM) projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the health care industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    For more information, contact:

    Amy Krohn
    Millennium Research Group
    416-364-7776 x101
    akrohn@mrg.net

    Elizabeth Marshall
    Decision Resources Inc.
    781-296-2563
    emarshall@dresources.com

SOURCE Millennium Research Group


'/>"/>
SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Warner Chilcott Completes Acquisition of P&Gs Global Branded Prescription Pharmaceuticals Business
2. Global Spinal Nonfusion Market to Reach Almost $2 Billion By 2013, According to Millennium Research Group
3. Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development
4. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
5. Global Vision Helps First Priority Reduce Costs in Tough Times
6. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
7. Frutarom Launches New Global Branding
8. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
9. $500 Billion Health Care Spend Boosts BRIC Countries Diagnostic Imaging Sales Despite Global Recession, According to Millennium Research Group
10. Otix Global Receives Nasdaq Bid Price Notice Deficiency
11. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Finally, a bruise cream that really ... cream can be incorporated into the post-surgical treatment plans of a variety of other ... dermaka cream is very effective for bruising and causes a rapid resolution of bruising ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Seema Daulat, a native Texan and University ... Lamar location as of July 13, 2016. , Dr. Daulat earned her Doctorate of ... she regularly volunteered at the Agape Clinic serving Dallas’ underprivileged community. , Following medical ...
(Date:6/23/2016)... ... 23, 2016 , ... SyncDog, Inc. , the leading ... is featured in the current issue of Silicon Review magazine. Silicon ... technology solutions and features them in their magazine. The magazine allows top-level executives ...
(Date:6/23/2016)... ... 23, 2016 , ... The U.S. Supreme Court decision on immigration has significant ... The Senior Citizens League (TSCL) . “President Obama’s executive actions on immigration would ... who worked in this country illegally, even though the newly - issued green cards ...
Breaking Medicine News(10 mins):